Advertisement
A demo

Catalyst Pharma sees net price of drug, once free, topping $300,000

Feb 12, 2019 , Reuters
Catalyst Pharmaceuticals Inc said on Monday that it expects its drug for a rare disease, which had long been available to patients for free, will cost more than $300,000 per year including rebates to insurers and other discounts.


Read the full story...


Trending healthcare news keywords at this moment

hospital cancer shows blood drug kids sleep risk heart disease flu measles study teen lives medicare care fda state patients healthcare launches tip data